The addition, which is privately funded, was originally estimated by White House officials to cost $200 million ANDREW CABALLERO-REYNOLDS / AFP via Getty Donald Trump announced the White House ...

President Trump on Tuesday indicated the cost of his planned ballroom project at the White House could reach $400 million, double the originally announced cost of $200 million. Trump spoke at length ...

Back in 2022, billionaire Mark Cuban launched Cost Plus Drugs, an online pharmaceutical marketplace geared toward reducing prescription medication costs for those who are currently uninsured or have ...

Mark Cuban (center), co-founder of Cost Plus Drugs explains his company's discussions with Humana to develop "direct-to-employer" prescription drug programs that bypass traditional pharmacy benefit ...

Forbes contributors publish independent expert analyses and insights. Bruce Japsen writes about healthcare business and policy. Cost Plus Drugs founder Mark Cuban (Center) speaks at the annual Forbes ...

NASHVILLE, TENNESSEE / ACCESS Newswire / December 4, 2025 / GraphiteRx and Mark Cuban Cost Plus Drugs today announced an expansion of their partnership to power the Cost Plus Marketplace for ...

Mark Cuban Cost Plus Drugs has expanded its partnership with GraphiteRx to support the Cost Plus Marketplace for Businesses. The platform combines Cost Plus Drugs’ pricing model with GraphiteRx’s ...

Among the handful of changes at Southwest Airlines is a new policy that will force plus-size people to purchase an extra seat in advance. The airline has struggled recently and is under pressure from ...

At a time when several highly-publicized class-action lawsuits have accused employers of overpaying for prescription drugs whose costs keep rising, the Rx benefits landscape may look daunting. But ...

Mark Cuban Cost Plus Drug Co. has added Starjemza, a biosimilar to Johnson & Johnson’s Stelara (ustekinumab), to its portfolio. The company, co-founded by billionaire entrepreneur Mark Cuban, is ...

DALLAS, Nov. 6, 2025 /PRNewswire/ -- Mark Cuban Cost Plus Drug Company (Cost Plus Drugs) today announced the addition of Starjemza®, a new biosimilar medication, to its growing portfolio of affordable ...